TY - JOUR
T1 - Contrast-enhanced computed tomography screening is efective for detecting venous thromboembolism not prevented by prophylaxis after total knee arthroplasty
AU - Okada, Yukimasa
AU - Furumatsu, Takayai
AU - Miyazawa, Shaichi
AU - Tanaka, Takaaki
AU - Fujii, Masataka
AU - Ozaki, Toshifumi
AU - Abe, Nobuhiro
N1 - Publisher Copyright:
© 2015 by Okayama University Medical School.
PY - 2015
Y1 - 2015
N2 - Venous thromboembolism (VTE) is a potential complication occurring after total knee arthroplasty (TKA). We investigated the incidence of VTE after TKA using contrast-enhanced computed tomography (CT), and assessed the efficacy of VTE prophylaxis (fondaparinux and enoxaparin). At our hospital, 189 patients (225 knees) underwent TKA between April 2007 and October 2011. The 225 knees were divided into a control group with no VTE prophylaxis (31 cases), a fondaparinux group (107 cases), and an enoxaparin group (87 cases). Contrast-enhanced CT screening for VTE was performed in all cases on day 5 or 6 after TKA. D-dimer levels were measured on day 5 after TKA, and were significantly lower in the fondaparinux (9.8 ± 3.8) and enoxaparin groups (9.4 ± 4.9) than in the control group (15.6 ± 9.8) (p < 0.001). However, no statistically significant difference in the incidence of VTE was observed among the groups (control, 61.3%; fondaparinux, 49.5%; enoxaparin, 50.6%). Prophylaxis was not effective for the prevention of VTE as detected by contrast-enhanced CT after TKA. CT should be performed after TKA, even when VTE prophylaxis is used.
AB - Venous thromboembolism (VTE) is a potential complication occurring after total knee arthroplasty (TKA). We investigated the incidence of VTE after TKA using contrast-enhanced computed tomography (CT), and assessed the efficacy of VTE prophylaxis (fondaparinux and enoxaparin). At our hospital, 189 patients (225 knees) underwent TKA between April 2007 and October 2011. The 225 knees were divided into a control group with no VTE prophylaxis (31 cases), a fondaparinux group (107 cases), and an enoxaparin group (87 cases). Contrast-enhanced CT screening for VTE was performed in all cases on day 5 or 6 after TKA. D-dimer levels were measured on day 5 after TKA, and were significantly lower in the fondaparinux (9.8 ± 3.8) and enoxaparin groups (9.4 ± 4.9) than in the control group (15.6 ± 9.8) (p < 0.001). However, no statistically significant difference in the incidence of VTE was observed among the groups (control, 61.3%; fondaparinux, 49.5%; enoxaparin, 50.6%). Prophylaxis was not effective for the prevention of VTE as detected by contrast-enhanced CT after TKA. CT should be performed after TKA, even when VTE prophylaxis is used.
KW - Contrast-enhanced computed tomography
KW - Enoxaparin
KW - Fondaparinux
KW - Total knee arthroplasty
KW - Venous thromboembolism
UR - http://www.scopus.com/inward/record.url?scp=84958177471&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84958177471&partnerID=8YFLogxK
M3 - Article
C2 - 26690246
AN - SCOPUS:84958177471
SN - 0386-300X
VL - 69
SP - 355
EP - 360
JO - Acta Medica Okayama
JF - Acta Medica Okayama
IS - 6
ER -